Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implicationsGaia Griguolo, Valentina Guarneri, Grazia Maria Vernaci et al.|npj Breast Cancer|2025Cited by 1